Cryptopolitan on MSN1h
Why Ripple Investors Are Jumping Ship to Lightchain AI to Outsmart Market Mayhem
Why are Ripple investors jumping ship to Lightchain AI to outsmart market mayhem? With over $17.3 million raised at a presale ...
Cryptopolitan on MSN9h
This Token’s Got Utility—and It’s Making Waves! Could It Be the Next Blockchain Beast?
This token’s got utility—and it’s making waves! With over $17.3 million raised at a presale price of $0.006, Lightchain AI is ...
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
Initiation of dosing in our Phase 1b clinical trial represents an important step in the clinical development of GT-02287 and in Gain’s mission to deliver a disease-modifying therapy to people with ...
Gain Therapeutics, Inc.: Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
Interim Analysis Expected End of 2Q 2025 BETHESDA, MD / ACCESS Newswire / March 14, 2025 / Gain Therapeutics, Inc. (Nasdaq:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company lead ...